United States · Markets & Finance · Bloomberg

Novartis Inks Chinese mRNA-Therapy Deal for Up to $7.8 Billion

Published by Bloomberg · United States 2 h ago

Novartis AG will license a messenger RNA-based autoimmune therapy from China’s Abogen Biosciences, in a deal worth as much as $7.8 billion.

Read the full article on Bloomberg Sign in to save

MediaNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.bloomberg.com)

Also worth reading

Trump’s Threat to Ban Diesel Exports Sets Off Global Alarms

Billionaire George Soros has donated $102 million ahead of the midterms—and now the Democrats are coming out ahead

ConocoPhillips Signs 20-Year LNG Deal With Venture Global

U.S. to send third carrier group to Mideast as Trump warns of new Iran strikes

Here’s what happened in crypto today

Business Insider

Milk Bar founder Christina Tosi shares the hiring approach she used to grow her bakery business